Business Context and Reporting Period
Company: Collegium Pharmaceutical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 10, 2016
Reporting Period: Quarterly period ended March 31, 2016
This filing serves as a notification that the company issued a press release on May 10, 2016, announcing its financial results for the quarter ended March 31, 2016. The full text of the press release is included as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the attached press release (Exhibit 99.1) which is furnished but not fully transcribed in this document.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative financial analysis.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. Such information is expected to be found in the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 10, 2016) for specific Q1 2016 financial results.
- Verify revenue, net loss, and cash burn rates in the attached press release.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the press release.
- Confirm liquidity position and cash runway as detailed in the full financial disclosure.